Skip to main content
. 2024 Nov 15;14(11):5304–5320. doi: 10.62347/EVMG4299

Figure 6.

Figure 6

Principle of this work. miR-503-5p promotes proliferation, invasion and EMT of HemECs and HUVECs by targeting BMPR1A. Note: BMPR1A, type IA bone morphogenetic protein receptor; HemECs, human hemangioma-derived endothelial cells; HUVECs, human umbilical vein endothelial cells.